TMC Life Sciences suspends GCEO; appoints temporary replacement


TMC Life Sciences Bhd group CEO Dr Melvin Heng Jun Li

PETALING JAYA: TMC Life Sciences Bhd has appointed director Dr Melvin Heng Jun Li as its group chief executive officer (GCEO) with immediate effect, following the suspension of Wan Nadiah Wan Mohd Abdullah Yaakob.

In a filing with Bursa Malaysia, the company said Wan Nadiah was also suspended as CEO of Thomson Hospitals Sdn Bhd, resulting in the powers, authorities and functions vested in her as the GCEO and CEO to be suspended with effect from Jan 29, 2024 until further announcement by the board.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
TMC Life Sciences , CEO , Melvin Heng Jun Li ,

Next In Business News

Ringgit likely to trade cautiously next week ahead of key US data
Watts from water
Singapore’s financial sector a big winner
Up in Arms - or up the value chain?
Asia bonds for diversification
Smart city can’t beat the traffic
Powering a new reinvestment cycle as demand surges
AI disruption fears rock markets
Private equity hits a sixer
Dubai luxe property keeps booming

Others Also Read